Literature DB >> 33710355

Variation and expression of HLA-DPB1 gene in HBV infection.

Guojin Ou1,2, Xiao Liu3, Haixia Xu4,5, Xin Ji4,5, Xiaojuan Liu6,7, Jue Wang8,9.   

Abstract

Hepatitis B virus (HBV) affects approximately 68 million people in China, and 10-15% of adults infected with HBV develop chronic hepatitis B, liver cirrhosis, liver failure or hepatocellular carcinoma (HCC). HLA-DPB1 gene polymorphism and expression have been shown to be associated with HBV infection susceptibility and spontaneous clearance. The aim of this study is to evaluate the role of HLA-DPB1 gene polymorphism in HBV infection. HLA-DPB1 and rs9277535 polymorphisms were investigated in 259 patients with HBV infection and 442 healthy controls (HCs) using sequence-based typing. The mRNA of HLA-DPB1 was measured by real-time polymerase chain reaction. HLA-DPB1 genes and rs9277535 polymorphisms were all associated with HBV infection in the Sichuan Han population. rs9277535A and HLA-DPB1*04:02 played a protective role against HBV infection. rs9277535G and DPB1*05:01 were associated with susceptibility to HBV infection. rs9277535GG had significantly higher HLA-DPB1 mRNA expression in the HBV infection group compared with the HC group. HLA-DPB1*05:01 and HLA-DPB1*21:01 had significantly lower mRNA expression in the HBV infection group compared with the HC group. The meta-analysis revealed that HLA-DPB1*02:01, HLA-DPB1*02:02, HAL-DPB1*04:01 and HLA-DPB1*04:02 protected against HBV infection, while HLA-DPB1*05:01, HLA-DPB1*09:01, and HLA-DPB1*13:01 were risk factors for susceptibility to HBV infection. HLA-DPB1*02:01, HLA-DPB1*02:02, and HLA-DPB1*04:01 were associated with HBV spontaneous clearance, while HLA-DPB1*05:01 was associated with chronic HBV infection. HLA-DPB1 alleles and rs9277535 have a major effect on the risk of HBV infection, and HBV infection is associated with lower HLA-DPB1 expression. HLA-DPB1 alleles have an important role in HBV susceptibility and spontaneous clearance.

Entities:  

Keywords:  Disease progression; Gene expression; HLA-DPB1 gene; Hepatitis B virus; Infection susceptibility; Spontaneous virus clearance

Year:  2021        PMID: 33710355     DOI: 10.1007/s00251-021-01213-w

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  33 in total

Review 1.  Mechanisms of HLA-DP Antigen Processing and Presentation Revisited.

Authors:  Mark Anczurowski; Naoto Hirano
Journal:  Trends Immunol       Date:  2018-11-08       Impact factor: 16.687

2.  HLA class II alleles in Chinese patients with hepatocellular carcinoma.

Authors:  P T Donaldson; S Ho; R Williams; P J Johnson
Journal:  Liver       Date:  2001-04

3.  Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.

Authors:  Lingmin Hu; Xiangjun Zhai; Jibin Liu; Minjie Chu; Shandong Pan; Jie Jiang; Yixin Zhang; Hua Wang; Jianguo Chen; Hongbing Shen; Zhibin Hu
Journal:  Hepatology       Date:  2012-03-16       Impact factor: 17.425

4.  HLA DPB1 15:01 Allele Predicts Spontaneus Hepatitis B Surface Antigen Seroconversion.

Authors:  Seyma Katrinli; G Nilay Karatas Erkut; Kamil Ozdil; Feruze Yilmaz Enc; Oguzhan Ozturk; Resul Kahraman; Ilyas Tuncer; Gizem Dinler Doganay; Levent Doganay
Journal:  Acta Gastroenterol Belg       Date:  2017 Jul-Sep       Impact factor: 1.316

5.  A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.

Authors:  Yoichiro Kamatani; Sukanya Wattanapokayakit; Hidenori Ochi; Takahisa Kawaguchi; Atsushi Takahashi; Naoya Hosono; Michiaki Kubo; Tatsuhiko Tsunoda; Naoyuki Kamatani; Hiromitsu Kumada; Aekkachai Puseenam; Thanyachai Sura; Yataro Daigo; Kazuaki Chayama; Wasun Chantratita; Yusuke Nakamura; Koichi Matsuda
Journal:  Nat Genet       Date:  2009-04-06       Impact factor: 38.330

6.  Association of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B.

Authors:  Levent Doganay; Arta Fejzullahu; Seyma Katrinli; Feruze Yilmaz Enc; Oguzhan Ozturk; Yasar Colak; Celal Ulasoglu; Ilyas Tuncer; Gizem Dinler Doganay
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

7.  Association of HLA-DP/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis.

Authors:  Yun Liao; Bei Cai; Yi Li; Jie Chen; Chuanmin Tao; Hengjian Huang; Lanlan Wang
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

8.  Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment.

Authors:  Xiaoyan Li; Liang Zhou; Lin Gu; Yurong Gu; Lubiao Chen; Yifan Lian; Yuehua Huang
Journal:  J Transl Med       Date:  2017-10-31       Impact factor: 5.531

9.  Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype level.

Authors:  Sung Won Cho; Jae Youn Cheong; Young Su Ju; Do Hoon Oh; Young Ju Suh; Kyung Wha Lee
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

10.  Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study.

Authors:  Yan Mardian; Yoshihiko Yano; Widya Wasityastuti; Neneng Ratnasari; Yujiao Liang; Wahyu Aristyaning Putri; Teguh Triyono; Yoshitake Hayashi
Journal:  Virol J       Date:  2017-10-23       Impact factor: 4.099

View more
  2 in total

1.  Genome-Wide Association Study for Chronic Hepatitis B Infection in the Thai Population.

Authors:  Saeideh Ashouri; Seik-Soon Khor; Yuki Hitomi; Hiromi Sawai; Nao Nishida; Masaya Sugiyama; Yosuke Kawai; Nawarat Posuwan; Pisit Tangkijvanich; Piyawat Komolmit; Makoto Tsuiji; Vorasuk Shotelersuk; Yong Poovorawan; Masashi Mizokami; Katsushi Tokunaga
Journal:  Front Genet       Date:  2022-06-13       Impact factor: 4.772

2.  The use of genomic variants to drive drug repurposing for chronic hepatitis B.

Authors:  Lalu Muhammad Irham; Wirawan Adikusuma; Dyah Aryani Perwitasari; Haafizah Dania; Rita Maliza; Imaniar Noor Faridah; Ichtiarini Nurullita Santri; Yohane Vincent Abero Phiri; Rocky Cheung
Journal:  Biochem Biophys Rep       Date:  2022-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.